Legacy Bridge’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,741
Closed -$357K 296
2024
Q1
$357K Sell
3,741
-402
-10% -$33.8K 0.21% 109
2023
Q4
$316K Hold
4,143
0.2% 111
2023
Q3
$287K Hold
4,143
0.2% 116
2023
Q2
$391K Sell
4,143
-780
-16% -$67.8K 0.26% 114
2023
Q1
$407K Sell
4,923
-1,113
-18% -$87.5K 0.28% 110
2022
Q4
$450K Buy
6,036
+44
+0.7% +$3.39K 0.32% 107
2022
Q3
$495K Sell
5,992
-6,002
-50% -$578K 0.39% 92
2022
Q2
$1.14M Sell
11,994
-25
-0.2% -$2.59K 0.84% 39
2022
Q1
$1.42M Sell
12,019
-3,305
-22% -$371K 0.83% 44
2021
Q4
$1.99M Sell
15,324
-214
-1% -$25K 1.03% 16
2021
Q3
$1.76M Sell
15,538
-1,612
-9% -$184K 1.01% 14
2021
Q2
$1.78M Sell
17,150
-470
-3% -$44.3K 1% 19
2021
Q1
$1.47M Buy
17,620
+1,193
+7% +$101K 0.95% 30
2020
Q4
$1.5M Buy
16,427
+750
+5% +$62.2K 1.09% 17
2020
Q3
$1.25M Buy
15,677
+433
+3% +$33.8K 1.14% 18
2020
Q2
$1.05M Sell
15,244
-1,163
-7% -$82.7K 1.16% 16
2020
Q1
$1.03M Sell
16,407
-708
-4% -$51.1K 1.3% 6
2019
Q4
$1.33M Buy
17,115
+1,935
+13% +$151K 1.11% 15
2019
Q3
$1.11M Sell
15,180
-1,341
-8% -$94.2K 1.06% 16
2019
Q2
$1.02M Buy
16,521
+300
+2% +$18.1K 0.98% 19
2019
Q1
$1.03M Hold
16,221
1.07% 11
2018
Q4
$828K Buy
+16,221
New +$821K 1.02% 17

Other funds holding EW

Legacy Bridge's EW Position: Q2 2024 in Review

Legacy Bridge sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 3,741 shares — an estimated $357K sold.

Legacy Bridge first reported a position in EW in Q4 2018 and held it in 22 quarters. The position peaked at $1.99M in Q4 2021. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Legacy Bridge reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Legacy Bridge sold 3,741 Edwards Lifesciences shares in Q2 2024, an estimated $357K.
  • Legacy Bridge first reported a position in Edwards Lifesciences in Q4 2018 and held it in 22 quarters.
  • Legacy Bridge's Edwards Lifesciences position peaked at $1.99M in Q4 2021.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Legacy Bridge's 13F filing for Q2 2024, filed 6 Aug 2024.